Please login to the form below

Not currently logged in
Email:
Password:

MM-398

This page shows the latest MM-398 news and features for those working in and with pharma, biotech and healthcare.

Baxter and Merrimack file pancreatic cancer drug in EU

Baxter and Merrimack file pancreatic cancer drug in EU

Baxter and Merrimack file pancreatic cancer drug in EU. MM-398 is thought to help direct the active drug into tumours. ... Analysts have suggested MM-398 could become a $500m-a-year product at peak.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics